2007
DOI: 10.1002/aoc.1343
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and structural characterization of diorganotin(IV) complexes with 2,6‐pyridinedicarboxylic acid

Abstract: SnI with 2,6-pyridinedicarboxylic acid, respectively in the presence of sodium methoxide or potassium iso-propoxide. The prepared compounds were characterized by mass spectrometry, IR, 1 H, 13 C and 119 Sn NMR spectroscopies. The molecular structures of both complexes were determined by a single-crystal X-ray analysis. The X-ray structure revealed pentagonal bipyramidal geometry around the tin atom for compound 1, which is incorporated with a hexacoordinated monosodium derivative of 2,6-pyridinedicarboxylic ac… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
17
0

Year Published

2009
2009
2019
2019

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 30 publications
(21 citation statements)
references
References 22 publications
2
17
0
Order By: Relevance
“…The design and synthesis of new organotin carboxylates by selecting ligands and organotin substrates has been encouraged in order to achieve efficacy. 2,6-pyridinedicarboxylic acid (Scheme 1) is a dicarboxylic acid containing an aromatic N donor atom, and some of its di-and trioganotin derivatives such as R 2 Sn(2,6-C 5 H 3 N)(COO) 2 (H 2 O) (R = Me, n-Bu) (Szorcsik et al, 2004a;Azadmeher et al, 2008), R 2 Sn(2,6-C 5 H 3 N)(COO) 2 (R = t-Bu, Ph, Et) (Gielen, 2002;Szorcsik et al, 2004b), 2,6-C 5 H 3 N(COOSnBu-n 3 ) 2 (Yin et al, 2007), 2,6-C 5 H 3 N(COOSnBu-n 3 ) 2 (4,4′-bpy) (Chandrasekhar et al, 2012) have been studied. In order to continue to expand the chemistry and therapeutic potential of the triorganotin/2,6-pyridinedicarboxylic acid compounds, we synthesized two new bis(triorganotin) 2,6-pyridinedicarboxylates from 2,6-pyridinedicarboxylic acid and triorganotin hydroxide and determined their in vitro cytotoxic activity.…”
Section: Introductionmentioning
confidence: 99%
“…The design and synthesis of new organotin carboxylates by selecting ligands and organotin substrates has been encouraged in order to achieve efficacy. 2,6-pyridinedicarboxylic acid (Scheme 1) is a dicarboxylic acid containing an aromatic N donor atom, and some of its di-and trioganotin derivatives such as R 2 Sn(2,6-C 5 H 3 N)(COO) 2 (H 2 O) (R = Me, n-Bu) (Szorcsik et al, 2004a;Azadmeher et al, 2008), R 2 Sn(2,6-C 5 H 3 N)(COO) 2 (R = t-Bu, Ph, Et) (Gielen, 2002;Szorcsik et al, 2004b), 2,6-C 5 H 3 N(COOSnBu-n 3 ) 2 (Yin et al, 2007), 2,6-C 5 H 3 N(COOSnBu-n 3 ) 2 (4,4′-bpy) (Chandrasekhar et al, 2012) have been studied. In order to continue to expand the chemistry and therapeutic potential of the triorganotin/2,6-pyridinedicarboxylic acid compounds, we synthesized two new bis(triorganotin) 2,6-pyridinedicarboxylates from 2,6-pyridinedicarboxylic acid and triorganotin hydroxide and determined their in vitro cytotoxic activity.…”
Section: Introductionmentioning
confidence: 99%
“…These unusual elongations of the Sn-N bond distances are due to the fact that Snatoms are not symmetrically coordinated to two axial Natoms, but rather to one N-and one O-atom. On the other hand, Sn1 is coordinated to the N-atom from the tbpe ligand (Sn1-N17 = 2.584 Å ), which is longer than the reported values [45][46][47][48][49][50] (Table 4). Thus, the non-equivalence of the tin-nitrogen bond lengths is notable.…”
Section: Resultsmentioning
confidence: 57%
“…Among these, acetates, benzoates and salicylates have attracted considerable interest from structural and biological viewpoints [5][6][7][8][9] . Structural diversity observed in metal carboxylates has significant influence of the preparation route on the structure of the final product 10 . ) is too low to account for dissociation reveals non electrolytic nature 15 .…”
Section: Introductionmentioning
confidence: 99%